Biotech Business - July 3, 2023
Lipigon signs 91 million USD deal with Leaderna Therapeutics
Lipigon Pharmaceuticals has entered a development and license agreement for its clinical-stage drug candidate Lipisense with Leaderna Therapeutics. The new agreement specifically involves the development and licensing of the drug in Greater China. Leaderna will be responsible for the development and commercialization of Lipisense in mainland China, Hong Kong, Taiwan and Macau (collectively known as […]
Financing - June 28, 2023
Moberg Pharma is recommended EU approval and proposes a rights issue
The company has announced that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended for national approval in 13 European countries for the treatment of mild to moderate fungal infections of the nails in adults. The Decentralized Procedure includes the following EU countries: Austria, Belgium, Czech Republic, Denmark, Finland, France, […]
Business - June 28, 2023
UBI’s Life science city project granted 14 million SEK
Umeå Biotech Incubator (UBI) has been granted financing for the ERDF project “Life science city”, which will further develop the life science industry in the region 2024-2026. ”It feels gratifying that we get to build on our long-term goal,” says UBI’s Operations coordinator, Peter Jacobsson. ”Developments in recent years have shown the potential in Life […]
Financing - June 26, 2023
Increasing home dialysis awarded 3 million EUR
Swedish company Cuviva is part of a new cross-border research initiative in health innovations and person-centred care. The project has been awarded almost 3 million EUR by the EU among others. The research focuses on increasing the use of home dialysis, which has been shown to provide significant benefits for patients’ quality of life and […]
Biotech Business - June 12, 2023
GutCRINE – First investment from the University of Copenhagen’s new investment company
The University of Copenhagen is the first Danish university to invest in a company based on its own research in unique collaboration with a venture fund. On April 11th 2023, the company GutCRINE ApS received an initial financing of 4 million DKK to begin development of a completely new class of biological medicines, so-called pharmabiotics. […]
Biotech Business - June 8, 2023
Mendus enters alliance with NorthX and announces a directed share issue
Mendus has entered into a manufacturing alliance with NorthX Biologics and has announced a directed share issue and a fully secured rights issue of units totaling approximately 317 million SEK in financing. In the alliance with NorthX, Mendus and NorthX will co-establish cell therapy manufacturing capabilities in Sweden, which will be used for late-stage development […]
